{"corpus_id":5916076,"paper_sha":"031e488ca22a7f0749012e88d3ebec1e639c795f","doi":"10.3233/DMA-2012-0904","arxiv_id":null,"pmid":22710864,"pmcid":"3810786","mag_id":2114808575,"dblp_id":null,"acl_id":null,"title":"Cancer Biomarker Discovery: Lectin-Based Strategies Targeting Glycoproteins","year":2012,"publication_date":"2012-06-14","venue":"Disease Markers","journal":{"name":"Disease markers","pages":"1 - 10","volume":"33"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Review"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":48,"citation_count":53,"influential_citation_count":0,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Biomarkers, Tumor","mj":false,"qs":[{"q":"analysis","mj":true,"ui":"Q000032"},{"q":"blood","mj":false,"ui":"Q000097"},{"q":"isolation & purification","mj":false,"ui":"Q000302"}],"ui":"D014408"},{"d":"Early Detection of Cancer","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D055088"},{"d":"Glycoproteins","mj":false,"qs":[{"q":"analysis","mj":true,"ui":"Q000032"},{"q":"blood","mj":false,"ui":"Q000097"},{"q":"isolation & purification","mj":false,"ui":"Q000302"}],"ui":"D006023"},{"d":"Glycosylation","mj":false,"ui":"D006031"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Lectins","mj":false,"qs":[{"q":"chemistry","mj":true,"ui":"Q000737"}],"ui":"D037102"},{"d":"Neoplasms","mj":false,"qs":[{"q":"blood","mj":false,"ui":"Q000097"},{"q":"diagnosis","mj":false,"ui":"Q000175"}],"ui":"D009369"},{"d":"Sensitivity and Specificity","mj":false,"ui":"D012680"}],"chemicals":[{"n":"Biomarkers, Tumor","ui":"D014408","reg":"0"},{"n":"Glycoproteins","ui":"D006023","reg":"0"},{"n":"Lectins","ui":"D037102","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://europepmc.org/articles/pmc3810786?pdf=render","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/031e488ca22a7f0749012e88d3ebec1e639c795f","s2_open_access_license":"unspecified-oa","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Biomarker discovery can identify molecular markers in various cancers that can be used for detection, screening, diagnosis, and monitoring of disease progression. Lectin-affinity is a technique that can be used for the enrichment of glycoproteins from a complex sample, facilitating the discovery of novel cancer biomarkers associated with a disease state.","claims":[{"public_id":"cl_561e510779a18ea6f0a2919ab167e417","status":"active","text":"Lectin-affinity can enrich glycoproteins from complex samples and thereby facilitate discovery of novel cancer biomarkers associated with disease state.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_561e510779a18ea6f0a2919ab167e417"}],"concepts":[{"public_id":"co_04bd48cb25e8f3e38baf9c6ed5cf10f0","status":"active","name":"disease state","description":"The pathological condition of an organism, used here as the context for biomarker association.","types":["condition"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_04bd48cb25e8f3e38baf9c6ed5cf10f0"},{"public_id":"co_3821e3377bf24cfb573473ddaad43b4b","status":"active","name":"lectin-affinity","description":"An affinity-based technique that uses lectins to bind and enrich glycoproteins from complex samples.","types":["method"],"aliases":["lectin affinity"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3821e3377bf24cfb573473ddaad43b4b"},{"public_id":"co_770281d91e462f4df937731a7a44e23d","status":"active","name":"detection","description":"Use of biomarkers to identify the presence of cancer.","types":["application"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_770281d91e462f4df937731a7a44e23d"},{"public_id":"co_8562961b19dc593a8c53bf7e2ef2df00","status":"active","name":"novel cancer biomarkers","description":"Previously unrecognized molecular markers associated with cancer.","types":["biomarker"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8562961b19dc593a8c53bf7e2ef2df00"},{"public_id":"co_902f7cfe6514bf9887c7058b7f32ca39","status":"active","name":"monitoring of disease progression","description":"Use of biomarkers to track changes in disease status over time.","types":["application"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_902f7cfe6514bf9887c7058b7f32ca39"},{"public_id":"co_a39f7ef550c50247e5e5a6c362c657cb","status":"active","name":"complex sample","description":"A heterogeneous biological sample containing many molecular components.","types":["sample"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_a39f7ef550c50247e5e5a6c362c657cb"},{"public_id":"co_aa847aff7656fcb0ce9c860ff5604e24","status":"active","name":"screening","description":"Use of biomarkers to identify disease in populations before symptoms appear.","types":["application"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_aa847aff7656fcb0ce9c860ff5604e24"},{"public_id":"co_d1b87eb87deb03108a74e27e9535a331","status":"active","name":"glycoproteins","description":"Proteins containing covalently attached carbohydrate moieties.","types":["biomolecule"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d1b87eb87deb03108a74e27e9535a331"},{"public_id":"co_d361bb2cbaefbe92ed7bc687d24aea25","status":"active","name":"diagnosis","description":"Use of biomarkers to support identification of a disease.","types":["application"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d361bb2cbaefbe92ed7bc687d24aea25"},{"public_id":"co_dd34db53d12d5e5514a7a8327f0c5644","status":"active","name":"cancer biomarker discovery","description":"The process of identifying molecular markers that can be used to detect or monitor cancer.","types":["research area"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_dd34db53d12d5e5514a7a8327f0c5644"},{"public_id":"co_e16973e19cf0867a3628f28eacec782f","status":"active","name":"lectin-based strategies","description":"Approaches that use lectins to target specific glycan-containing molecules.","types":["method"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e16973e19cf0867a3628f28eacec782f"}],"external_ids":{"DOI":"10.3233/DMA-2012-0904","ArXiv":null,"PubMed":22710864,"PubMedCentral":"3810786","MAG":2114808575,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://europepmc.org/articles/pmc3810786?pdf=render","landing_url":"https://www.semanticscholar.org/paper/031e488ca22a7f0749012e88d3ebec1e639c795f","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"unspecified-oa","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":636265,"paper_uid":"8de46ddd-7483-4698-bf33-f70bb229a1cb","canonical_identity":{"paper_id":636265,"paper_uid":"8de46ddd-7483-4698-bf33-f70bb229a1cb","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/5916076"}